Jump to:
C |
D |
P |
R |
SNumber of items: 8.
C
Clingen, P.H. and De Silva, I.U. and McHugh, P.J. and Ghadessy, F.J. and Tilby, M.J. and Thurston, D.E. and Hartley, J.A. (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks inmammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. An open access publication | |
Clingen, P.H. and De Silva, I.U. and McHugh, P.J. and Ghadessy, F.J. and Tilby, M.J. and Thurston, D.E. and Hartley, J.A. (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. An open access publication. A version is also available from UCL Discovery. |  |
D
de la Fuente, J and Richards, S and Webb, DK and Hann, IM and Mitchell, CD and Vora, AJ and Kinsey, SE and Eden, OB and Ancliff, P (2005) Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial). Blood , 106 (11) 256A - 257A. | |
P
Peggs, K.S. and Hunter, A. and Chopra, R. and Parker, A. and Mahendra, P. and Milligan, D. and Craddock, C. and Pettengell, R. and Dogan, A. and Thomson, K.J. and Morris, E.C. and Hale, G. and Waldmann, H. and Goldstone, A.H. and Linch, D.C. and Mackinnon, S. (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7. | |
R
Rudd, R.M. and Gower, N.H. and Spiro, S.G. and Eisen, T.G. and Harper, P.G. and Littler, J.A.H. and Hatton, M. and Johnson, P.W.M. and Martin, W.M.C. and Rankin, E.M. and James, L.E. and Gregory, W.M. and Qian, W. and Lee, S.M. (2005) Gemcitabine plus Carboplatin versus Mitomycin, Ifosfamide, and Cisplatin in patients with stage IIIB or IV non–small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. An open access version is available from UCL Discovery |  |
Rudd, R.M. and Gower, N.H. and Spiro, S.G. and Eisen, T.G. and Harper, P.G. and Littler, J.A.H. and Hatton, M. and Johnson, P.W.M. and Martin, W.M.C. and Rankin, E.M. and James, L.E. and Gregory, W.M. and Qian, W. and Lee, S.M. (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. 10.1200/JCO.2005.03.037. | |
S
Sharma, S.K. and Pedley, R.B. and Bhatia, J. and Boxer, G.M. and El-Emir, E. and Qureshi, U. and Tolner, B. and Lowe, H. and Michael, N.P. and Minton, N. and Begent, R.H.J. and Chester, K. (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clinical Cancer Research , 11 (2) pp. 814-825. | |
This list was generated on Sat May 18 08:40:43 2013 BST.